LiverLearning®: 2021 Webinar: PSC and Hepatic Fibrosis: An Update from the Field
This webinar coincided with PSC Awareness Day. We highlighted PSC in terms of disease pathology and curative options open to patients suffering from PSC.
A Diagnostic Test Meta‐Analysis Evaluating Imaging‐Based and Blood Biomarker–Based Assessment Tools for Fibrosis After Liver Transplantation
Cheng Han Ng, Darren Jun Hao Tan, Xiong Chang Lim, Jie Ning Yong, Nicholas Syn, Gwyneth Shook Ting Soon, Daniel Q. Huang, Jieling Xiao, Grace En Hui Lim, Wen Hui Lim, Eunice Xiang Xuan Tan, Yock Young Dan, Mazen Noureddin, Mohammad Shadab Siddiqui, Mark D. Muthiah – 28 October 2021 – Early detection of liver graft fibrosis is crucial for risk stratification to identify patients for liver biopsy and timely treatment. However, diagnostic accuracy of noninvasive tests (NITs) remains unclear.
Risk Factors for Hepatocellular Carcinoma: A Historical Perspective
Yamini Natarajan, Hashem B. El‐Serag – 28 October 2021
Rappaport, Glisson, Hering, and Mall—Champions of Liver Microanatomy: Microscopic and Ultramicroscopic Anatomy of the Liver Into the Modern Age
Ryan M. Gill, Neil D. Theise – 28 October 2021
A Brief History of Hepatic Encephalopathy
Nathan M. Bass – 28 October 2021
Role of Novel Kidney Biomarkers in Patients With Cirrhosis and After Liver Transplantation
Sumeet K. Asrani, Nagasri Shankar, Briget Graca, Mitra K. Nadim, Andres Cardenas – 28 October 2021 – Acute kidney injury (AKI) and chronic kidney disease (CKD) are important drivers of morbidity and mortality in patients with cirrhosis before and after liver transplantation (LT). In this review, we examine the role of novel kidney biomarkers for early recognition of kidney injury. Studies are limited by lack of reference standards, heterogeneous definitions of outcomes and biomarker cutoffs, and inconsistent diagnostic performance.
A History of the Assessment of Liver Performance
Omar Y. Mousa, Patrick S. Kamath – 28 October 2021
A Historical Overview of Spontaneous Bacterial Peritonitis: From Rare to Resistant
Lamia Y. Haque, Guadalupe Garcia‐Tsao – 28 October 2021
Validation of Dynamic Aspartate‐to–Alanine Aminotransferase Ratio for Predicting Liver Disease Mortality
In‐Ae Song, Eun Sun Jang, Tak Kyu Oh – 28 October 2021 – The dynamic aspartate‐to–alanine aminotransferase ratio (dAAR) was developed recently to predict the risk of incident chronic liver disease among the Nordic adult population; however, the dAAR has not been externally validated in other ethnic cohorts. Therefore, we aimed to examine the predictive ability of dAAR for liver disease mortality in the South Korean adult population.
Alcohol‐Related Liver Disease
Kyle Robinson, Vijay H. Shah – 28 October 2021